ReShape Lifesciences Inc. (RSLS)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.18M |
| Enterprise Value | -21.64k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.12 |
| Price/Book (mrq) | 0.63 |
| Enterprise Value/Revenue | -0.00 |
| Enterprise Value/EBITDA | 0.00 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.30 |
| 52-Week Change 3 | -92.16% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 2.7980 |
| 52 Week Low 3 | 0.1410 |
| 50-Day Moving Average 3 | 0.1687 |
| 200-Day Moving Average 3 | 0.4687 |
Share Statistics
| Avg Vol (3 month) 3 | 496.8k |
| Avg Vol (10 day) 3 | 187.94k |
| Shares Outstanding 5 | 23.46M |
| Implied Shares Outstanding 6 | 23.46M |
| Float 8 | 20.82M |
| % Held by Insiders 1 | 11.16% |
| % Held by Institutions 1 | 1.97% |
| Shares Short (Apr 15, 2024) 4 | 487.78k |
| Short Ratio (Apr 15, 2024) 4 | 1.18 |
| Short % of Float (Apr 15, 2024) 4 | 2.33% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.08% |
| Shares Short (prior month Mar 15, 2024) 4 | 428.69k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jul 25, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:50 |
| Last Split Date 3 | Dec 23, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -131.22% |
| Operating Margin (ttm) | -95.61% |
Management Effectiveness
| Return on Assets (ttm) | -83.92% |
| Return on Equity (ttm) | -220.59% |
Income Statement
| Revenue (ttm) | 8.68M |
| Revenue Per Share (ttm) | 1.46 |
| Quarterly Revenue Growth (yoy) | -36.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -14.48M |
| Net Income Avi to Common (ttm) | -11.39M |
| Diluted EPS (ttm) | -1.9100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.46M |
| Total Cash Per Share (mrq) | 0.19 |
| Total Debt (mrq) | 262k |
| Total Debt/Equity (mrq) | 3.93% |
| Current Ratio (mrq) | 2.73 |
| Book Value Per Share (mrq) | 0.28 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16.96M |
| Levered Free Cash Flow (ttm) | -11.7M |
© 2024 Yahoo. All rights reserved.